Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.60 |
| ▸ | PGK1 | P00558 | 6/20 | 0.44 |
| ▸ | PGK2 | P07205 | 6/20 | 0.44 |
| ▸ | ANPEP | P15144 | 1/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.42 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.41 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ACP3 | P15309 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9301497 | 0.87 | SRC (0.75) | SRCPGK1PGK2MAPTACP3 | |
| SCHEMBL16931008 | 0.81 | ACP3 (0.57) | SRCPGK1PGK2ANPEPERAP2 | |
| SCHEMBL2171583 | 0.80 | SRC (0.65) | SRCPGK1PGK2ACP3CA14 | |
| SCHEMBL744283 | 0.79 | PGK1 (0.59) | SRCPGK1PGK2ANPEPERAP2 | |
| SCHEMBL15397888 | 0.79 | ANPEP (0.44) | SRCPGK1PGK2ANPEPERAP2 | |
| SCHEMBL5936840 | 0.78 | SRC (0.62) | SRCPGK1PGK2GRM8GRM4 | |
| SCHEMBL2637390 | 0.77 | PGK1 (0.41) | SRCPGK1PGK2ANPEPERAP2 | |
| SCHEMBL4093802 | 0.76 | SRC (0.60) | SRCPGK1PGK2MAPTTHRB | |
| SCHEMBL1552133 | 0.76 | SRC (0.60) | SRCPGK1PGK2MEN1KMT2A | |
| Phosphoric Acid SCHEMBL6267680 | 0.76 | MEN1 (0.57) | ANPEPERAP2FDPSMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170306157-A1 | Modified Colorants and Inkjet Ink Compositions Comprising Modified Colorants | CABOT CORP (US) | 2017-10-26 | — | — | US | disclosed |
| US-9732227-B2 | Modified colorants and inkjet ink compositions comprising modified colorants | CABOT CORPORATION (US) | 2017-08-15 | — | — | US | disclosed |
| EP-3040382-A1 | MODIFIED COLORANTS AND INKJET INK COMPOSITIONS COMPRISING MODIFIED COLORANTS | Cabot Corporation (US) | 2016-07-06 | — | — | EP | disclosed |
| US-20160075880-A1 | Modified Colorants and Inkjet Ink Compositions Comprising Modified Colorants | CABOT CORPORATION | 2016-03-17 | — | — | US | disclosed |
| US-8858695-B2 | Modified colorants and inkjet ink compositions comprising modified colorants | CABOT CORPORATION (US) | 2014-10-14 | — | — | US | disclosed |
| EP-2431427-A1 | Modified colorants and inkjet ink compositions comprising modified colorants | Cabot Corporation (US) | 2012-03-21 | — | — | EP | disclosed |
| EP-2431426-A1 | Modified colorants and inkjet ink compositions comprising modified colorants | Cabot Corporation (US) | 2012-03-21 | — | — | EP | disclosed |
| EP-2431425-A1 | Modified colorants and inkjet ink compositions comprising modified colorants | Cabot Corporation (US) | 2012-03-21 | — | — | EP | disclosed |
| US-20080287396-A1 | Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections | TARGANTA THERAPEUTICA INC. (CA) | 2008-11-20 | — | — | US | disclosed |
| EP-1951821-A2 | MODIFIED COLORANTS AND INKJET INK COMPOSITIONS COMPRISING MODIFIED COLORANTS | Cabot Corporation (US) | 2008-08-06 | — | — | EP | disclosed |
| EP-1881974-A2 | PHOSPHONATED FLUOROQUINOLONES, ANTIBACTERIAL ANALOGS THEREOF, AND METHODS FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS | Targanta Therapeutics Inc. (CA) | 2008-01-30 | — | — | EP | disclosed |
| WO-2007053564-A2 | MODIFIED COLORANTS AND INKJET INK COMPOSITIONS COMPRISING MODIFIED COLORANTS | CABOT CORPORATION (US) | 2007-05-10 | — | — | WO | disclosed |
| US-20070100024-A1 | Modified colorants and inkjet ink compositions comprising modified colorants | CABOT CORPORATION | 2007-05-03 | — | — | US | disclosed |
| WO-2007017762-A2 | PHOSPHONATED FLUOROQUINOLONES, ANTIBACTERIAL ANALOGS THEREOF, AND METHODS FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS | TARGANTA THERAPEUTICS INC. (CA) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287396-A1 | Phosphonated Fluoroquinolones, Antibacterial Analogs Thereof, and Methods for the Prevention and Treatment of Bone and Joint Infections | BPGM, PSPH, PGLS | SRC 1714/4885PGK1 393/4885PGK2 526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.